Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus.

Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus. Abstract Text:

    christopher dunnChristopher Dunn,monique p curranMonique P Curran,

    Inhaled human insulin (Exubera((R)) [insulin human (rDNA origin)] Inhalation Powder) has recently been approved in the EU and the US for preprandial use in adult patients with diabetes mellitus. This formulation of insulin has a more rapid onset, but similar duration, of glucose-lowering activity compared with subcutaneously administered regular human insulin.Preprandial inhaled human insulin provided glycemic control that was comparable to preprandial subcutaneous regular insulin when added to long- or intermediate-acting subcutaneous basal insulin in patients with type 1 diabetes. Inhaled human insulin is also effective when administered alone, when combined with oral antihyperglycemic therapy, or when combined with basal subcutaneous insulin in patients with type 2 diabetes. Comparable rates of hypoglycemia occurred in patients treated with inhaled human insulin and in those treated with subcutaneous regular human insulin. Patients treated with inhaled human insulin demonstrated a greater decline in pulmonary function (forced expiratory volume in 1 second, carbon monoxide diffusing capacity) than patients treated with comparator antihyperglycemic agents; the mean difference between the treatment groups that favored the comparators was noted within the first several weeks of treatment, and did not change over a 2-year treatment period. This agent has also been associated with significant improvements in some quality-of-life and treatment satisfaction scores, especially when compared with subcutaneous mealtime insulin regimens.

    Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus. Publishing Authors By Initials

    c dunnC Dunn,mp curranMP Curran,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Treatments in endocrinology

    VOLUME: 5

    Page Numbers: 329-31

    Journal Abbreviation:

    ISSN: 1175-6349

    DAY: 27

    MONTH: 09

    YEAR: 2006

    Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101132977

    Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Spotlight on inhaled human insulin (exubera((r))) in diabetes mellitus.

    AFFILIATION: Adis International Inc., Yardley, Pennsylvania, USA.

    Country: New Zealand

    New Zealand Research PublicationNew Zealand Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Treat Endocrinol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Spotlight on inhaled human insulin exuberar in diabetes mellitus Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News